Corcept Therapeutics Inc

Ownership Transactions Reported by 15 Insiders

Symbol
CORT on Nasdaq
Location
101 Redwood Shores Parkway, Redwood City, California

Insiders trading volume in the past year

Corcept Therapeutics Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Joseph K. Belanoff Chief Executive Officer, Director $117M Jul 31, 2024
G. Leonard Baker Jr Director $117M May 17, 2024
James N. Wilson Director $62M May 23, 2024
David Mahoney Director $30.6M May 17, 2024
Hazel Hunt Chief Scientific Officer $4.5M Aug 1, 2024
Sean Maduck Officer $3.26M -$6.14M -65.3% Sep 3, 2024
Gary Charles Robb Chief Business Officer $1.14M -$1.17M -50.7% Sep 3, 2024
Atabak Mokari Chief Financial Officer $429K Sep 3, 2024
Joseph Douglas Lyon Chief Accounting & Technology Officer $339K -$1.37M -80.1% Sep 3, 2024
William Guyer Chief Development Officer $205K -$2.66M -92.9% Sep 3, 2024
Daniel N. Swisher JR Director $0 -$577K -100% Aug 1, 2024
Joshua M. Murray Director May 17, 2024
Kimberly Park Director May 17, 2024
Gillian Cannon Director May 17, 2024
Gregg H. Alton Director May 17, 2024

Recent Insider Transactions by Companies or Individuals for Corcept Therapeutics Inc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.